M&A Deal Summary

Hikma Acquires Bedford Laboratories

On July 15, 2014, Hikma acquired life science company Bedford Laboratories for 300M USD

Acquisition Highlights
  • This is Hikma’s 2nd transaction in the Life Science sector.
  • This is Hikma’s 2nd largest (disclosed) transaction.
  • This is Hikma’s 3rd transaction in the United States.
  • This is Hikma’s 1st transaction in Ohio.

M&A Deal Summary
Date 2014-07-15
Target Bedford Laboratories
Sector Life Science
Buyer(s) Hikma
Deal Type Add-on Acquisition
Deal Value 300M USD

Target

Bedford Laboratories

Bedford, Ohio, United States
Bedford Laboratories, Inc. provides generic intellectual property rights, contracts for products marketed under license, raw material inventories, a strong R&D and business development pipeline and a number of employees across key business functions.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Hikma

London, United Kingdom
Category Company
Founded 1978
Sector Medical Products
Employees9,100
Revenue 2.9B USD (2023)
DESCRIPTION

Hikma develops, manufactures, and markets a broad range of branded and non-branded generic and in-licensed products. Hikma operates through three businesses: “Branded”, “Injectables” and “Generics”, based principally in the Middle East and North Africa ("MENA"), where it is a market leader, the United States and Europe. Hikma was founded in 1978 and is based in London, England.

DEAL STATS #
Overall 7 of 10
Sector (Life Science) 2 of 4
Type (Add-on Acquisition) 6 of 8
State (Ohio) 1 of 1
Country (United States) 3 of 4
Year (2014) 1 of 1
Size (of disclosed) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-01-22 Egyptian for Pharmaceuticals & Chemical Industries

Egypt

Egyptian Co. for Pharmaceuticals & Chemical Industries is a manufacturer of pharmaceutical products.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-09-08 EIMC United Pharma

Cairo, Egypt

EUP is a pharmaceutical manufacturing company specialising in oncology products. The company operates in therapeutic segments like Oncology, Anesthesia, Cardiac, and Rheumatology. EIMC United Pharma offers oncology and intensive care products such as Sterile Oncology, Sterile Non-Oncology, Capsules, Tablets, and Liquid Dosage forms

Buy -
Mergr

Product

Company

Legal